# CYCLOPHOSPHAMIDE
> **ANDA218282** · Abbreviated New Drug Application (Generic) · Sponsor: EIRGEN · Approved 2024-12-03
## Drug
- **FDA Application Number:** ANDA218282
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CYCLOPHOSPHAMIDE
- **Generic name:** CYCLOPHOSPHAMIDE
- **Active ingredients:** CYCLOPHOSPHAMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EIRGEN
- **Manufacturer:** OPKO Pharmaceuticals, LLC
- **First approval:** 2024-12-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218282)
---
*AI Analytics · CC0 1.0*